-
Morgan Stanley Reaffirms Overweight Rating for Silence Therapeutics (NASDAQ:SLN)
Source: Buzz FX / 08 Oct 2024 13:36:11 America/New_York
Morgan Stanley Reaffirms Overweight Rating for Silence Therapeutics (NASDAQ:SLN) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Silence Therapeutics ( NASDAQ:SLN - Get Free Report ) 's stock had its "overweight" ratin
Read more...